Navigation Links
Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
Date:1/11/2008

Message: Early Detection and Prevention Saves Lives!

PHILADELPHIA, Jan. 11 /PRNewswire/ -- Each year, about 11,000 women in the United States are diagnosed with cervical cancer and 3,700 women die unnecessarily from this disease(1). In recognition of Cervical Cancer Awareness month, Independence Blue Cross will make more than 100,000 member outreach calls reminding women that early detection and prevention of cancer can help save lives.

During this educational campaign, Independence Blue Cross will remind women ages 21-49 to receive their cervical cancer screening. In addition, women will be encouraged to discuss the Human Papillomavirus (HPV) vaccine, which is recommended for girls ages 11-12 and females ages 13-26, with their health care providers. HPV is one of the most common sexually transmitted infections in the United States and most cases of cervical cancer are associated with previous HPV infection.

Independence Blue Cross is providing this important reminder to members because research shows that receiving the three-shot HPV vaccine and recommended cervical cancer Pap test screening can decrease the chance of developing cervical cancer(2). However, it is important to note that even if a woman has had the HPV vaccine, she will continue to require regular cervical cancer screening by the Pap test and the HPV test when recommended(2).

"Our goal is to help keep our members healthy today, tomorrow, and well into the future," Says Dr. Esther Nash, senior medical director of Population Health and Wellness at Independence Blue Cross. "Prevention is a key. Providing important reminders about health screenings and vaccinations, wellness education, and increasing members' awareness of consumer tools and resources available to them are just some of the ways we're helping to keep our members feeling great in '08 and beyond."

For more information about cervical cancer prevention, or for help locating a participating gyne
'/>"/>

SOURCE Independence Blue Cross
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Independence Blue Cross Makes Music for Members Ears
2. Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission
3. Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center
4. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
5. Independence Blue Cross Announces No Pay Getaway Promotion Designed to Encourage Healthy Behaviors
6. Independence Blue Cross and Abington Memorial Hospital Reach Multi-Year Agreement
7. Independence Blue Cross Gives Grants to Support Health Care for the Uninsured
8. Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross
9. Breast cancer prevention practices vary across Canada
10. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
11. S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ation and treatment clinics to resume Monday, Nov....ovember 25, 2009 -- Centegra Health System is cont...ne shots at four Centegra Primary Care (CPC) vacci...as arrived. The clinics are at CPC sites in Huntle... open as follows: ,   From 4:30 to 7:3...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...re/-- MISSIONSkincare ®isproudtosupportGNC,se...NC,sannualSt.Jude ThanksandGiving campaign,$1fromt...ER-C(TM)LipBalm willbedonatedtoSt.Jude.Additionall...onationatcheckoutatoneoftheir5,000+retaillocations...Judeduringtheir2009 ThanksandGiving campaign. ,...
(Date:11/25/2009)...nforthe4thStraightYear ,, WASHINGTON,Nov.25/P...Georgia(LCA-GA)issuedthe 4thAnnualReportCardonLung...eagainstthislethaldiseaseinthestateofGeorgia.LCA-G...alorganizationdedicatedexclusivelytopatientsupport...r. ,, (Logo: http://www.newscom.com/cgi-bin/prn...
(Date:11/25/2009)...al cancer also can reverse a rare stomach disorder...he disease, researchers at Vanderbilt University M...se causes thickening of the stomach lining, severe...nemia and swelling in the feet and ankles due to p...stric cancer. Previously, the only effective treat...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...an research groups are undertaking pioneering stud...ing to patients receiving new drug treatments as e...fessor Shaun Jackson from The Australian Centre fo...tigating the impact of the bone marrow microenviro...
...arch 9, 2009 An easily implementable technique to...ed through angioplasty and stent insertion has bee...nsky of the Hebrew University of Jerusalem. , A... to part of the beating heart, usually due to plaq...
...n California Practice to Join SpectraScience Netwo...ystem , , SAN DIEGO, March 9 SpectraScience, Inc...dical device company, today announced that it has ... founder of Women,s Integrative Health, stated, "W...
...March 9 CEL-SCI Corporation (NYSE Alternext US: C...clusive licensing agreement with Byron Biopharma (...exclusive license to market and distribute the Com...th Teva Pharmaceuticals and Orient Europharma. , ...
... Journal of Radiation Oncology*Biology*Physics Stu...stem Provides Enhanced Image Information for Plann...REAL, March 4 Researchers report in the February ... enhanced image information to enable radiation on...
...., March 9 VirtualHealth Technologies, Inc. (OTC ...ve immediately it,s subsidiary Envoii Healthcare, ...o better reflect it,s focus on eHealth Security pr...t on growing our opportunities in this evolving cl...
Other Medicine News:Health News:World first treatment for leukemia being developed in Australia 2Health News: Hebrew University scientist develop technique for eliminating reblockage of arteries 2Health News:Women's Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System 2Health News:Women's Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System 3Health News:CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa 2Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 2Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 3Health News:Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region 4Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 2Health News:Envoii Healthcare, LLC is now Secure eHealth, LLC 3
(Date:11/25/2009)....,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.tod...iefexecutiveofficer,willpresentatthePiperJaffray21...1,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fer...gantibioticclinicalprogramsforthetreatmentofdrug-r...Pharmaceuticals ,, Foundedin2006,CempraPharmac...
(Date:11/25/2009)...alif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,anno...y,sPROTECT-1(theProspectiveRandomizedOralTherapyEv...X282-B)inpatientswithmoderate-to-severeCrohn,sdise...yandtolerabilityprofile.Thestudydemonstratedeviden...yasdefinedasa70-pointdecreaseintheCrohn,sDiseaseAc...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRM...nofReorganizationandDisclosureStatementtoday,Novem...eDistrictofDelaware.Ahearingtoconsiderapprovalofth...r8,2009,withthehearingontheconfirmationofthePlansc...ompanytopayallclaimsinfull.ThePlanisexpected,ifapp...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 1Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 2Sunesis Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia 6012 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 1Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 2Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 3Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 4Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 5Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 6Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 7Amgen Announces Overall Survival Results for Vectibix 28R 29 in First Line Metastatic Colorectal Cancer 6010 8Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 1Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 2Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 3
... increase in advanced non-small cell, lung cancer ...clitaxel and cisplat...include reductions in chemotherapy-indu...OKYO, March 18 BioNumerik,Pharmaceuticals, Inc. (...ASKA") today announced the results of a Phase III ...
... 2b in Second Quarter of 2008 - - Conferen... DIEGO, March 17 Ardea Biosciences, Inc.,(Nasdaq:...lts from its,ongoing Phase 2a proof-of-concept stu...oside reverse transcriptase inhibitor (NNRTI), in,... Preliminary results from the first two of three ...
Other Medicine Technology:BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 2BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 3BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 4BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM) 5Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4
UPJ Occlusion Balloon Catheter
Omega NV Balloon Ureteral Dilator Sets
AquaGuide Ureteral Access Sheath
Flexible Ureteroscopy Sheath Set
Medicine Products: